Douglas D. Lazarus

ScholarGPS® ID: 51498308070003

Affiliation

Praecis Pharmaceuticals, Inc.

Affiliation History

Field

Pharmacy and Pharmaceutical Sciences

Discipline

Pharmacology and Toxicology

Top Specialties

Arthritis

Metrics Summary

Publication Count

Predicted Citations

178

Predicted h-index

Ranking

Publications and Citation History

Add Delete
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis (journal article) Lazarus, D. D. \| Doyle, E. G. \| Bernier, S. G. \| Rogers, A. B. \| Labenski, M. T. \| Wakefield, J. D. \| Karp, R. M. \| Clark, E. J. \| Lorusso, J. \| Hoyt, J. G. \| ... \| Westlin, W. F. Inflammation Research, volume 57, issue 1, pages 18-27 (2008). 10.1007/s00011-007-7075-5 Cited by (13) \| Cite \| Source
A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis (journal article) Bernier, Sylvie G. \| Lazarus, Douglas D. \| Clark, Edward \| Doyle, Beth \| Labenski, Matthew T. \| Thompson, Charles D. \| Westlin, William F. \| Hannig, Gerhard Proceedings of the National Academy of Sciences, volume 101, issue 29, pages 10768-10773 (2004). 10.1073/pnas.0404105101 Cited by (109) \| Cite \| Source \| Open Access

Delete

Inflammation Research, volume 57, issue 1, pages 18-27 (2008).

Proceedings of the National Academy of Sciences, volume 101, issue 29, pages 10768-10773 (2004).